Sotera Health Company $SHC Position Increased by Corient Private Wealth LLC

Corient Private Wealth LLC boosted its stake in shares of Sotera Health Company (NASDAQ:SHC) by 217.4% in the fourth quarter, HoldingsChannel reports. The firm owned 44,342 shares of the company’s stock after purchasing an additional 30,373 shares during the quarter. Corient Private Wealth LLC’s holdings in Sotera Health were worth $773,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in SHC. CenterBook Partners LP boosted its holdings in shares of Sotera Health by 94.1% in the fourth quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock worth $2,673,000 after buying an additional 73,473 shares during the period. Capricorn Fund Managers Ltd acquired a new stake in shares of Sotera Health during the fourth quarter valued at approximately $7,936,000. Nordea Investment Management AB acquired a new stake in shares of Sotera Health during the fourth quarter valued at approximately $1,908,000. Exchange Traded Concepts LLC purchased a new stake in shares of Sotera Health in the 4th quarter valued at approximately $7,739,000. Finally, Retirement Systems of Alabama boosted its stake in Sotera Health by 16.9% in the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock worth $4,391,000 after purchasing an additional 35,974 shares during the period. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Stock Performance

NASDAQ SHC opened at $17.93 on Friday. The company’s fifty day moving average is $15.97 and its two-hundred day moving average is $16.35. Sotera Health Company has a 52-week low of $10.94 and a 52-week high of $19.85. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The firm has a market capitalization of $5.11 billion, a price-to-earnings ratio of 43.73 and a beta of 1.76.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. During the same quarter in the prior year, the business earned $0.14 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities research analysts forecast that Sotera Health Company will post 0.88 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Barclays lifted their price objective on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Piper Sandler reaffirmed an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. UBS Group set a $19.00 price target on Sotera Health in a report on Wednesday, June 24th. The Goldman Sachs Group assumed coverage on Sotera Health in a research report on Friday, June 5th. They set a “buy” rating and a $20.00 price target on the stock. Finally, Weiss Ratings downgraded Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Sotera Health has an average rating of “Moderate Buy” and a consensus price target of $20.25.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 15.36% of the stock is currently owned by company insiders.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.